Gene · 3003
NIH grants2,103
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1,241 to 1,260 of 2,103
Download this page as JSON| Grant | Title | GZMK papers | Newest fiscal year |
|---|---|---|---|
| T32GM008152 | Medical Scientist Training Program | 1 | 2021 |
| T32GM008208 | Medical Scientist Training Program | 1 | 2021 |
| T32GM008629 | Predoctoral Training Program in Genetics | 1 | 2021 |
| T32HG008955 | Postdoctoral training in genomic medicine research | 1 | 2021 |
| U01AI101981 | Prevention Center U01: Early Targets for Antigen-Specific Tolerance Induction in Preclinical Rheumatoid Arthritis | 1 | 2021 |
| U01AI129825 | 3BNC117 and 10-1074 to suppress HIV-1 replication and reduce the reservoir | 1 | 2021 |
| U01AI131386 | High Precision System Analysis of Infant Immune Responses | 1 | 2021 |
| U01AI131566 | Determining how macrophages regulate immunity to Zika virus infection at the maternal-fetal interface | 1 | 2021 |
| U01CA176058 | The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center | 1 | 2021 |
| U01CA206997 | Imaging of nanotherapeutic drug action | 1 | 2021 |
| U01CA214125 | MICROSCALED PROTEOGENOMICS FOR CANCER CLINICAL TRIALS | 1 | 2021 |
| U01CA224145 | Interrupting Cellular Crosstalk in the Immunosuppressive Microenvironment of Pancreas Cancer | 1 | 2021 |
| U01CA224146 | Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens | 1 | 2021 |
| U01HD092308 | The impact of in utero HIV exposure on infant T and B cell responses in Malawi | 1 | 2021 |
| U01HG009391 | Connecting transposable elements and regulatory innovation using ENCODE data | 1 | 2021 |
| U19AI118610 | Dengue Human Immunology Project Consortium (DHIPC) | 1 | 2021 |
| U19AI133524 | Defining regulators of immunity to acute infection using CRISPR screens | 1 | 2021 |
| U19MH114821 | A Comprehensive Center for Mouse Brain Cell Atlas | 1 | 2021 |
| U2CCA233238 | The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy | 1 | 2021 |
| U34TR003594 | Network-driven drug repurposing in cardiovascular disease: NDRA clinical trial planning | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/grants?page=63